By Dr. Sanchari Sinha Dutta, Ph.D.Jul 15 2024 Scientists at Washington State University, USA, have conducted a clinical trial to investigate the acute effect of cannabigerol on anxiety, stress, and mood in healthy individuals. They have published the trial findings in the journal Scientific Reports.
Cannabigerol is a precursor of many other phytocannabinoids, including delta-9-tetrahydrocannabinol, cannabidiol, and cannabichromene. Thus, it is often regarded as the “mother of all cannabinoids.” In the first online session, participants were informed about the upcoming drug testing session and provided with all necessary information and instructions.
After one week of the first testing session, they completed the second testing session, which was identical to the first session except for the fact that the intervention and placebo drugs were switched between the study groups in a double-blinded manner. A significant improvement in verbal memory was observed in the cannabigerol group participants compared to that in the control group participants. Furthermore, no negative impact of cannabigerol was observed on motor or cognitive functioning.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NewsMedical - 🏆 19. / 71 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »